Clinical Trial Update: Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effects of salbutamol and ipratropium bromide in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)
• Salbutamol (salbutamol)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: COPD | Phase 4 | Status: COMPLETED